Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |